9,9-dimethyl-6,7,8,9-tetrahydro-benzocyclohepten-5-one | 3345-09-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 9,9-dimethyl-6,7,8,9-tetrahydro-benzocyclohepten-5-one
• 英文别名: 9,9-Dimethyl-6,7,8,9-tetrahydro-benzocyclohepten-5-on；9,9-dimethyl-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-one；7,7-Dimethyl-1,2-benzocycloheptenon-(3)；5,5-Dimethyl-1-benzosuberon；5,5-dimethyl-7,8-dihydro-6H-benzo[7]annulen-9-one
• CAS: 3345-09-3
• 化学式: C₁₃H₁₆O
• 分子量: 188.269
• InChiKey: CKKXFFDTFYRIDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  9,9-dimethyl-6,7,8,9-tetrahydro-benzocyclohepten-5-one 在 potassium tert-butylate 、 水 、 sodium 作用下， 以 甲醇 为溶剂， 生成 4,4-Dimethylbenzocyclopropacyclohepten
  参考文献：
  名称：

  Three-membered rings. III. Ultraviolet spectral evidence of a stereochemical bias in rigid p-nitrophenylcyclopropanes

  摘要：

  DOI：

  10.1021/jo00979a015
• 作为产物：
  描述：

  5-Methyl-5-phenylhexansaeuremethylester 在 PPA 作用下， 生成 9,9-dimethyl-6,7,8,9-tetrahydro-benzocyclohepten-5-one
  参考文献：
  名称：

  Three-membered rings. III. Ultraviolet spectral evidence of a stereochemical bias in rigid p-nitrophenylcyclopropanes

  摘要：

  DOI：

  10.1021/jo00979a015

文献信息

• Substituted guanidine derivatives and process for producing the same
  申请人：Sumitomo Pharmaceuticals Company

  公开号：US06369110B1

  公开（公告）日：2002-04-09

  A compound represented by the general formula (1): wherein each of R1, R2, R3, R4 and R5 is a hydrogen atom, an alkyl group, a substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, a saturated heterocyclic group, an aromatic group, an acyl group or the like; each of Y1, Y2, Y3 and Y4 is a single bond, —CH2—, —O—, —CO— or the like, provided that at least two of Y1 through Y4 are independently a group other than a single bond; and Z may be absent, or one or more Zs may be present and are independently an alkyl group, a substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, a saturated heterocyclic group, a halogen atom, a carboxyl group, an alkoxycarbonyl group, an aromatic group, an acyl group or the like, is useful as a therapeutic or prophylactic agent for diseases caused by the acceleration of the sodium/proton exchange transport system.

  通式（1）所代表的化合物： 其中R1、R2、R3、R4和R5中的每一个是氢原子、烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和杂环基、芳香基、酰基或类似物；Y1、Y2、Y3和Y4中的每一个是单键、—CH2—、—O—、—CO—或类似物，前提是至少两个Y1到Y4中的独立团是单键以外的团；以及Z可以不存在，或者一个或多个Z可以存在且独立地是烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和杂环基、卤素原子、羧基、烷氧羰基、芳香基、酰基或类似物，对于由于钠/质子交换传输系统加速而引起的疾病，具有治疗或预防作用。
• Aminoethanol derivatives
  申请人：——

  公开号：US20040127574A1

  公开（公告）日：2004-07-01

  The present invention provides a pharmaceutical agent having cholesteryl ester transfer protein inhibitory action and useful as a blood lipid lowering agent and the like. The present invention relates to a compound represented by the formula 1 wherein Ar 1 is an aromatic ring group optionally having substituents, Ar 2 is an aromatic ring group having substituents, OR″ is an optionally protected hydroxyl group, R is an acyl group, R′ is a hydrogen atom or a hydrocarbon group optionally having substituents, or a salt thereof, and a pharmaceutical composition containing a compound of the formula (I) or a salt thereof or a prodrug thereof.

  本发明提供了一种具有胆固醇酯转移蛋白抑制作用的药物剂，可用作降低血脂等方面的药物。本发明涉及一种由式1表示的化合物，其中Ar1是一个带有取代基的芳香环基团，Ar2是一个带有取代基的芳香环基团，OR″是一个可选保护的羟基，R是一个酰基，R′是一个氢原子或一个可选带有取代基的碳氢基团，或其盐，以及含有式(I)的化合物或其盐或前药的药物组合物。
• AMINOETHANOL DERIVATIVES
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1362846A1

  公开（公告）日：2003-11-19

  The present invention provides a pharmaceutical agent having cholesteryl ester transfer protein inhibitory action and useful as a blood lipid lowering agent and the like. The present invention relates to a compound represented by the formula wherein Ar1 is an aromatic ring group optionally having substituents, Ar2 is an aromatic ring group having substituents, OR'' is an optionally protected hydroxyl group, R is an acyl group, R' is a hydrogen atom or a hydrocarbon group optionally having substituents, or a salt thereof, and a pharmaceutical composition containing a compound of the formula (I) or a salt thereof or a prodrug thereof.

  本发明提供了一种具有胆固醇酯转移蛋白抑制作用的药剂，可用作降血脂药等。本发明涉及一种由式表示的化合物 其中 Ar1 是可选具有取代基的芳香环基，Ar2 是可选具有取代基的芳香环基，OR''是可选保护的羟基，R 是酰基，R'是氢原子或可选具有取代基的烃基，或其盐，以及含有式（I）化合物或其盐或其原药的药物组合物。
• Metal complexes
  申请人：Merck Patent GmbH

  公开号：US11024815B2

  公开（公告）日：2021-06-01

  The present invention relates to metal complexes and to electronic devices, especially organic electroluminescent devices, comprising these metal complexes, especially as emitters, and in particular monometallic metal complex containing a hexadentate tripodal ligand in which three bidentate sub-ligands coordinate to a metal and the three bidentate sub-ligands, which may be the same or different, are joined via a bridge.

  本发明涉及金属络合物和包含这些金属络合物的电子器件，特别是有机电致发光器件，尤其是作为发光体的金属络合物，特别是含有六价三足配位体的单金属络合物，其中三个双齿次配位体与金属配位，三个双齿次配位体（可以相同或不同）通过桥连接。
• Conformations of Seven-Membered Rings. Benzocycloheptenes
  作者：Harold Hart、James L. Corbin

  DOI：10.1021/ja01092a023

  日期：1965.7